Chen et al[85] found that CHE significantly inhibited the stemness of OS cancer stem cell markers (including Nanog, Oct4 and nestin) by regulating the PI3K/AKT/mTOR signaling axis, and also decreased the expression of MMP-2/9 protein, so as to inhibit the malignant behavior of CSC. The gene discussed is AKT1; the disease is cancer.